In a significant development for investors in Reckitt Benckiser Group PLC (OTC: RBGLY), Rosen Law Firm, renowned for defending investor rights globally, has initiated a class action lawsuit targeting alleged securities fraud perpetrated against shareholders. This lawsuit spans a critical timeframe from January 13, 2021, to July 28, 2024. Investors who purchased American Depositary Shares (ADSs) during this period may have the opportunity to seek compensation for potential losses incurred as a result of misleading information presented by the company.
Understanding the Allegations
The core allegations of the lawsuit focus on Reckitt's failure to adequately inform shareholders about significant risks related to its products. Specifically, the lawsuit highlights that Reckitt's cow's milk-based formula, Enfamil, could increase the risk of necrotizing enterocolitis (NEC) in preterm infants. This oversight is alleged to have affected the sales of Enfamil and opened the company up to potential legal claims, which ultimately misled investors about the company's operational prospects and financial health.
Timing and Importance of Participation
Those interested in leading the class action must apply to the court by August 4, 2025, and timely action is crucial as no class has yet been certified. This is a significant point for potential plaintiffs, as opting to join the action does not require them to pay any out-of-pocket costs, under a contingency fee arrangement.
For those who wish to participate, the Rosen Law Firm has established a streamlined process for joining the class action. Interested investors can visit
Rosen Legal's submission page or contact attorney Phillip Kim at 866-767-3653 for detailed guidance on next steps. By joining, investors will have the chance to recover lost funds without incurring upfront legal expenses.
Why Choose Rosen Law Firm?
Rosen Law Firm is established for its successes in prosecuting securities class actions and represents investors across the globe. Their formidable track record speaks for itself, having secured the largest securities class action settlement against a Chinese company historically, and consistently ranking among the top firms nationally for their settlements. They have recovered hundreds of millions of dollars for investors and are recognized for their experienced attorneys who have earned accolades from various legal publications.
Next Steps for Investors
Investors have a choice to either actively participate in litigation as a lead plaintiff or remain passive members of the class without immediate legal representation. However, even without joining the lawsuit, the ability of an investor to benefit from any potential settlement won’t be affected.
To stay updated on proceedings and further developments, stakeholders are encouraged to follow Rosen Law Firm's official social media channels, including LinkedIn, Twitter, and Facebook.
In conclusion, the class action lawsuit against Reckitt Benckiser presents a vital opportunity for investors to potentially secure compensation for losses associated with the alleged securities fraud. Prompt action is recommended for those who feel they may be affected and wish to participate in this significant legal undertaking.